FMC updates Q3 outlook: revenue $65M–$125M; Adjusted EBITDA negative $565M to $510M
FMC updated its Q3 outlook, expecting revenue of $65M–$125M and adjusted EBITDA of -$565M to -$510M due to commercial actions. The company anticipates $625M–$675M impact from these actions. FMC also flagged a potential impairment evaluation of intangible assets by September 30, 2026, and plans to engage lenders about covenant modifications.
How this was made
The 30-second read
Why it matters
The guidance cut reflects a $625‑$675M adverse impact, prompting a likely sell‑off in the stock as investors adjust earnings expectations.
Market read
The new outlook is material for FMC shareholders and may affect peer agribusiness stocks.
What to watch
Potential covenant compliance and upcoming lender discussions could provide financing stability despite the guidance cut.
Background
FMC Corp (NYSE:FMC) released an 8‑K on Oct. 15, 2026 outlining new Q3 guidance after implementing price‑reduction initiatives across several markets.
Ticker impact
FMC issued a fresh 8‑K updating Q3 revenue to $65‑$125M and adjusted EBITDA to a $565‑$510M loss, a new guidance cut not previously reported.
likely pressure as the market prices in the lower revenue and EBITDA outlook.
The disclosed $625‑$675M adverse impact from commercial actions directly reduces earnings expectations, prompting traders to reassess valuation.
Market effects
Signals potential pricing pressure in the agricultural chemicals sector as distributors face inventory challenges.
Highlights tighter pricing dynamics in North America and South America (Brazil, Argentina, Canada).
May influence broader commodity‑linked agribusiness stocks that rely on similar distribution models.
Counterpoint
If the commercial actions successfully clear inventory, the short‑term earnings hit could be offset by longer‑term market share gains.
Key entities
- companyFMC Corp
U.S. agricultural chemicals producer issuing the guidance update.
